Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yann Godet

Showing results (21-30 of 51) with videos related to

Pageof 6
Sort By:
Cancer Immunology, Immunotherapy : CII|July 29, 2006
Infusion of Melan-A/Mart-1 specific tumor-infiltrating lymphocytes enhanced relapse-free survival of melanoma patientsHoussem Benlalam, Virginie Vignard, Amir Khammari, et al.
The Journal of Investigative Dermatology|August 5, 2021
Naturally Occurring Telomerase-Specific CD4 T-Cell Immunity in MelanomaCharlée Nardin, Caroline Laheurte, Eve Puzenat, et al.
Frontiers in Immunology|March 28, 2024
Characterization of atypical T cells generated during <i>ex vivo</i> expansion process for T cell-based adoptive immunotherapyPatricia Mercier-Letondal, Abhishek Kumar, Chrystel Marton, et al.
Plos One|October 14, 2014
Immunogenicity evaluation of a rationally designed polytope construct encoding HLA-A*0201 restricted epitopes derived from Leishmania major related proteins in HLA-A2/DR1 transgenic mice: steps toward polytope vaccineNegar Seyed, Tahereh Taheri, Charline Vauchy, et al.
Cancer Immunology, Immunotherapy : CII|May 13, 2025
Characterization of the aryl hydrocarbon receptor as a potential candidate to improve cancer T cell therapiesValentine De Castro, Oumaïma Abdellaoui, Barbara Dehecq, et al.
Human Gene Therapy|August 24, 2018
Isolation and Characterization of an HLA-DRB1*04-Restricted HPV16-E7 T Cell Receptor for Cancer ImmunotherapyPatricia Mercier-Letondal, Chrystel Marton, Marina Deschamps, et al.
Oncotarget|November 22, 2018
Personalized identification of tumor-associated immunogenic neoepitopes in hepatocellular carcinoma in complete remission after sorafenib treatmentSindy Vrecko, David Guenat, Patricia Mercier-Letondal, et al.
International Journal of Cancer|December 3, 2014
CD20 alternative splicing isoform generates immunogenic CD4 helper T epitopesCharline Vauchy, Clementine Gamonet, Christophe Ferrand, et al.
Oncoimmunology|April 11, 2018
SALL4 oncogene is an immunogenic antigen presented in various HLA-DR contextsMarie Kroemer, Laurie Spehner, Patricia Mercier-Letondal, et al.
Journal for Immunotherapy of Cancer|November 24, 2020
Investigation of the prognostic value of CD4 T cell subsets expanded from tumor-infiltrating lymphocytes of colorectal cancer liver metastasesMarie Kroemer, Celia Turco, Laurie Spehner, et al.
Pageof 6

Showing results (21-30 of 51) with videos related to

Sort By:
Pageof 6
Cancer Immunology, Immunotherapy : CII|July 29, 2006
Infusion of Melan-A/Mart-1 specific tumor-infiltrating lymphocytes enhanced relapse-free survival of melanoma patientsHoussem Benlalam, Virginie Vignard, Amir Khammari, et al.
The Journal of Investigative Dermatology|August 5, 2021
Naturally Occurring Telomerase-Specific CD4 T-Cell Immunity in MelanomaCharlée Nardin, Caroline Laheurte, Eve Puzenat, et al.
Frontiers in Immunology|March 28, 2024
Characterization of atypical T cells generated during <i>ex vivo</i> expansion process for T cell-based adoptive immunotherapyPatricia Mercier-Letondal, Abhishek Kumar, Chrystel Marton, et al.
Plos One|October 14, 2014
Immunogenicity evaluation of a rationally designed polytope construct encoding HLA-A*0201 restricted epitopes derived from Leishmania major related proteins in HLA-A2/DR1 transgenic mice: steps toward polytope vaccineNegar Seyed, Tahereh Taheri, Charline Vauchy, et al.
Cancer Immunology, Immunotherapy : CII|May 13, 2025
Characterization of the aryl hydrocarbon receptor as a potential candidate to improve cancer T cell therapiesValentine De Castro, Oumaïma Abdellaoui, Barbara Dehecq, et al.
Human Gene Therapy|August 24, 2018
Isolation and Characterization of an HLA-DRB1*04-Restricted HPV16-E7 T Cell Receptor for Cancer ImmunotherapyPatricia Mercier-Letondal, Chrystel Marton, Marina Deschamps, et al.
Oncotarget|November 22, 2018
Personalized identification of tumor-associated immunogenic neoepitopes in hepatocellular carcinoma in complete remission after sorafenib treatmentSindy Vrecko, David Guenat, Patricia Mercier-Letondal, et al.
International Journal of Cancer|December 3, 2014
CD20 alternative splicing isoform generates immunogenic CD4 helper T epitopesCharline Vauchy, Clementine Gamonet, Christophe Ferrand, et al.
Oncoimmunology|April 11, 2018
SALL4 oncogene is an immunogenic antigen presented in various HLA-DR contextsMarie Kroemer, Laurie Spehner, Patricia Mercier-Letondal, et al.
Journal for Immunotherapy of Cancer|November 24, 2020
Investigation of the prognostic value of CD4 T cell subsets expanded from tumor-infiltrating lymphocytes of colorectal cancer liver metastasesMarie Kroemer, Celia Turco, Laurie Spehner, et al.
Pageof 6